The total market value of RWA surpasses 65 billion dollars, with Ethereum leading at a 33% market share.
ChainCatcher news, according to The Block, as traditional asset management companies accelerate bringing tokenized assets on-chain, the total market value of real-world assets (RWA) has surpassed $65 billion, an increase of about 44% since the beginning of the year. Ethereum holds around 33% of the market share, maintaining its position as the default platform for institutional tokenization. Provenance blockchain accounts for about 27% of the market share, while BNB Chain, XRP Ledger, and Solana each account for about 6%.
The distributed market structure indicates that there is not yet a clear winner in the RWA sector. Different chains set themselves apart in terms of compliance tools, settlement finality, and cost structure, leaving significant room for market share movements. Since RWA capital is highly sticky, blockchains that secure institutional partnerships early will gain lasting advantages.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Supply disruptions ease, oil market bears “swiftly gather”: Brent put option bets surge to unprecedented levels
Oil traders are flocking to buy options, betting on a decline in Brent crude. As investors reposition after a sharp rise in oil prices over the past few trading sessions, bearish bets have surged to unprecedented levels.

Bridgford Foods VP Richard Eugene Bridgford acquires USD 2,054.5 in common shares
New York Federal Reserve official: U.S. Treasury purchases have no preset path, will closely monitor financing market pressures in October
Lorie K. Logan, head of the New York Fed's Markets Group, stated that the Federal Reserve will continue to assess the reserve levels within the banking system. The purchase of U.S. Treasuries for reserve management does not follow a predetermined path and may be adjusted in the future based on market conditions.
Structure Therapeutics CMO Blas Coll Crespo disposes of USD 124,008 common shares
